The Ukrainians can freely join start-up programs and take part in investigations in order to experience new possibilities of medicine. This is an opinion of Dmytro Shymkiv, the Chairman of the Board of Directors of Darnitsa Group, expressed by him at Health Tech Talk panel discussion organized by the European Business Association with the support of Darnitsa and Philips companies.
The top manager said with confidence that the Health Tech rapid development across technology, medicine and pharmaceutics had made prophylaxis and treatment of many diseases more available. Nowadays patients can choose among multiple monitoring tools of health biomarkers and early diagnosis of disease gradually formed herewith. Another trend is to use artificial intelligence and machine learning that make it possible to process accumulated information along with biodata and give recommendations. It refers to cardiology, muscular condition, pressure parameters and other things.
According to Shymkiv, twenty-four-hour health state monitoring of millions of people will result in accumulation of a large database analyzed by artificial intelligence (AI). New possibilities are open when it is applied. In particular, Darnitsa, Pharmaceutical Company, studies the AI implementation to improve business operations overall and investigations in patients’ adherence to treatment.
The managers of Darnitsa Group consider artificial intelligence to apply it in silico investigations. There are no respective platforms developed in Ukraine yet, and specialists of the company study experience of the USA. Darnitsa’s second development trend is to search for new ways of use of the already known molecules.
The Chairman of the Board of Directors of the pharmaceutical concern emphasized that the Covid-19 pandemic had speeded up telemedicine development. In Ukraine there are start-ups that invest in that. On the whole, it increased by 35%-40% under the influence of the coronacrisis. A doctor’s visit will become a thing of the past, and a primary consultation “via a computer network” will be absolutely real. It will solve another problem, that is shortage of physicians all over the world. However, correct diagnosis is known to be a part of success. Often patients need long term therapy or surgical intervention. In that case, the future is in medical robots according to Dmytro Shymkiv.
Among other important trends the top-manager of Darnitsa Group mentioned the so-called personalized drugs that are systems to identify individual dosages and dynamics of drug treatment being tested in Ukraine as well according to Dmytro Shymkiv. The digital therapeutic trend is also relevant, when in addition to medicines and procedures patients are prescribed mobile applications, which functions can be to track and correct such psychological conditions as posttraumatic syndrome, in particular. Nowadays such applications are already used in treatment of neurosis, for example. They track a sleep stage or tranquilize brain with a specially developed game.
Dmytro Shymkiv said that all top international pharmaceutical companies have branches engaged in digiceuticals. And Darnitsa Group is not an exclusion. Its managers study start-ups and possibilities of partnership. According to the top manager’s forecast, Darnitsa will not only offer pills and infusions but also healing applications after a while.
Source: Plato Data Intelligence
